Literature DB >> 27827465

Ki-67 expression in pulmonary tumors.

Lucian R Chirieac1.   

Abstract

Entities:  

Year:  2016        PMID： 27827465      PMCID： PMC5099507          DOI： 10.21037/tlcr.2016.10.13

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  60 in total

Review 1.  Ki-67 staining as a means to simplify analysis of tumor cell proliferation.

Authors:  C L Hitchcock
Journal:  Am J Clin Pathol       Date:  1991-10       Impact factor: 2.493

2.  Neuroendocrine lung tumors: grade correlates with proliferation but not angiogenesis.

Authors:  Z K Arbiser; J L Arbiser; C Cohen; A A Gal
Journal:  Mod Pathol       Date:  2001-12       Impact factor: 7.842

3.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.

Authors:  J Gerdes; U Schwab; H Lemke; H Stein
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

4.  Utility of SKP2 and MIB-1 in grading follicular lymphoma using quantitative imaging analysis.

Authors:  Kai Zhang; Jeffrey W Prichard; Shawn Yoder; Jitakshi De; Fan Lin
Journal:  Hum Pathol       Date:  2007-03-12       Impact factor: 3.466

5.  Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid.

Authors:  W D Travis; W Rush; D B Flieder; R Falk; M V Fleming; A A Gal; M N Koss
Journal:  Am J Surg Pathol       Date:  1998-08       Impact factor: 6.394

6.  Cell-cycle analysis detecting endogenous nuclear antigens: comparison with BrdU-in vivo labeling and an application to lung tumors.

Authors:  Y Hayashi; M Fukayama; M Koike; S Kaseda; T Ikeda; T Yokoyama
Journal:  Acta Pathol Jpn       Date:  1993-06

7.  Cranial computed tomography as a part of the initial staging procedures for patients with non-small-cell lung cancer.

Authors:  D Ferrigno; G Buccheri
Journal:  Chest       Date:  1994-10       Impact factor: 9.410

Review 8.  Ki-67 antigen in lung neuroendocrine tumors: unraveling a role in clinical practice.

Authors:  Giuseppe Pelosi; Guido Rindi; William D Travis; Mauro Papotti
Journal:  J Thorac Oncol       Date:  2014-03       Impact factor: 15.609

9.  ERCC1 and Ki67 in small cell lung carcinoma and other neuroendocrine tumors of the lung: distribution and impact on survival.

Authors:  Birgit Guldhammer Skov; Bente Holm; Anders Erreboe; Torsten Skov; Anders Mellemgaard
Journal:  J Thorac Oncol       Date:  2010-04       Impact factor: 15.609

10.  Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis.

Authors:  B Martin; M Paesmans; C Mascaux; T Berghmans; P Lothaire; A-P Meert; J-J Lafitte; J-P Sculier
Journal:  Br J Cancer       Date:  2004-12-13       Impact factor: 7.640
View more
  6 in total

1.  Spontaneous Partial Regression of a Carcinoid Tumor: Radiology May Not Capture the Real Picture.

Authors:  Ashok Kuwal; Nishant Chauhan; Naveen Dutt; Poonam Elhence; Manish Advani; Sunil Kumar
Journal:  Turk Thorac J       Date:  2019-01-31

2.  Surface-engineered nanostructured lipid carrier systems for synergistic combination oncotherapy of non-small cell lung cancer.

Authors:  Shruti Rawal; Vivek Bora; Bhoomika Patel; Mayur Patel
Journal:  Drug Deliv Transl Res       Date:  2020-11-19       Impact factor: 4.617

3.  Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation.

Authors:  José Miguel Pardo-Sánchez; Nuria Mancheño; José Cerón; Carlos Jordá; Emilio Ansotegui; Óscar Juan; Sarai Palanca; Antonio Cremades; Carolina Gandía; Rosa Farràs
Journal:  Cancers (Basel)       Date:  2021-06-14       Impact factor: 6.639

4.  Prognostic significance of pyroptosis-related factors in lung adenocarcinoma.

Authors:  Ximing Lin; Tian Zhou; Shaopu Hu; Lihui Yang; Zepei Yang; Haoyue Pang; Xiangnan Zhou; Ruikang Zhong; Xueni Fang; Zhongyang Yu; Kaiwen Hu
Journal:  J Thorac Dis       Date:  2022-03       Impact factor: 2.895

Review 5.  Survival Benefit of Adjuvant Chemotherapy in Pulmonary Carcinoid Tumors.

Authors:  Philip T Sobash; Asad Ullah; Nagla Abdel Karim
Journal:  Cancers (Basel)       Date:  2022-09-28       Impact factor: 6.575

6.  Lung gene expression signatures suggest pathogenic links and molecular markers for pulmonary tuberculosis, adenocarcinoma and sarcoidosis.

Authors:  Qiyao Chai; Zhe Lu; Zhidong Liu; Yanzhao Zhong; Fuzhen Zhang; Changgen Qiu; Bingxi Li; Jing Wang; Lingqiang Zhang; Yu Pang; Cui Hua Liu
Journal:  Commun Biol       Date:  2020-10-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.